Scott Peak
Impact in
Papers in
- Genetics 6
- Glioma Diagnosis and Treatment 6
-
- CNS Lymphoma Diagnosis and Treatment 2
- Co-authors
- Lauren E. Abrey (3 shared papers)Lisa Marie DeAngelis (1 shared paper)Meltem Ekenel (1 shared paper)Adı́lia Hormigo (1 shared paper)Orestes E. Solis (1 shared paper)Louis Fehrenbacher (1 shared paper)Michael T. Selch (1 shared paper)Linda M. Liau (1 shared paper)
- Journals
- Journal of Neuro-Oncology (2 papers)Journal of Clinical Oncology (1 paper)The Lancet Oncology (1 paper)Neuro-Oncology (1 paper)Cancer Discovery (1 paper)
- Partner nations
- United StatesIsrael
In The Last Decade
Scott Peak
11 papers receiving 2.3k citations
Scott Peak's Hit Papers
Peers
Comparison fields: 5 of 69
- Genetics 1.4k
- Neurology 256
- Immunology 224
- Oncology 253
- Pulmonary and Respiratory Medicine 177
Countries citing papers authored by Scott Peak
This map shows the geographic impact of Scott Peak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Peak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Peak more than expected).
Fields of papers citing papers by Scott Peak
This network shows the impact of papers produced by Scott Peak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Peak. The network helps show where Scott Peak may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Peak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial Hit paper breakdown → | 2017 | 938 |
| 2 | 2010 | 395 | |
| 3 | Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma Hit paper breakdown → | 2022 | 334 |
| 4 | Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma Hit paper breakdown → | 2017 | 325 |
| 5 | 2007 | 133 | |
| 6 | 2019 | 67 | |
| 7 | 2015 | 58 | |
| 8 | 2007 | 42 | |
| 9 | 2008 | 32 | |
| 10 | 2006 | 10 | |
| 11 | 2006 | 3 |
About Scott Peak
Scott Peak is a scholar working on Genetics, Neurology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 11 papers that have together received 2.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Radiopharmaceutical Chemistry and Applications (1 paper) and Multiple Sclerosis Research Studies (1 paper). The work is most often cited by research in Genetics (1.4k citations), Neurology (256 citations), Immunology (224 citations), Oncology (253 citations) and Pulmonary and Respiratory Medicine (177 citations). Scott Peak has collaborated with scholars based in United States and Israel. Frequent co-authors include Lauren E. Abrey, Lisa Marie DeAngelis, Meltem Ekenel, Adı́lia Hormigo, Orestes E. Solis, Louis Fehrenbacher, Michael T. Selch, Linda M. Liau, William H. Yong and Albert Lai. Their work appears in journals such as Journal of Neuro-Oncology, Journal of Clinical Oncology, The Lancet Oncology, Neuro-Oncology and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.